Related Experiment Video
Updated: Jun 24, 2026

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Regional origin and decrease of pain in patients with depressive symptoms under treatment with venlafaxine
Stefan Begré1, Martin Traber, Martin Gerber
1Division of Psychosomatic Medicine, Department of General Internal Medicine, University Hospital/Inselspital, 3010, Bern, Switzerland. stefan.begre@insel.ch
Regional origin impacts treatment outcomes for pain and depression. Middle European patients showed greater improvement with venlafaxine compared to Eastern and Southern European patients, highlighting disparities in care.
Area of Science:
- Psychiatry and Psychosomatic Medicine
- Clinical Pharmacology
Background:
- Patient background, including language and cultural factors, influences the doctor-patient relationship and treatment outcomes.
- Sociocultural disparities and language barriers may affect pain and depression recovery in specific patient populations.
Purpose of the Study:
- To investigate the influence of regional origin on treatment outcomes for pain and depression.
- To compare the efficacy of venlafaxine in patients from different European regions.
Main Methods:
- Prospective, naturalistic observational trial involving 420 patients with depressive symptoms and pain.
- Treatment with venlafaxine administered by 122 primary care physicians.
- Assessment of depression severity and pain intensity using validated scales.
Main Results:
- Middle European patients demonstrated greater improvement in depression severity and pain intensity compared to Eastern and Southern European patients after three months.
- Venlafaxine treatment efficacy varied based on patients' regional origin.
Conclusions:
- Regional origin is a significant factor influencing pain reduction in patients with depressive symptoms treated with venlafaxine.
- Educational programs for healthcare providers are recommended to improve care for patients with psychosomatic complaints from diverse backgrounds.
More Related Videos
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
08:33A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Related Concept Videos
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Depressive Disorders: MDD and Dysthymia
The Placebo Effect